Fatty liver disease (MASLD/MASH): open trials in Argentina

8 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Buenos Aires · Ciudad Autónoma de Buenos Aires · La Plata · Ramos Mejía
Registry updated 2026-11-06
NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Centro de Investigaciones Metabólicas (CINME), Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires · Mautalen Salud e Investigación, Buenos Aires · CIPREC, Buenos Aires · Glenny Corp - Centro Medico Saavedra, Buenos Aires · Buenos Aires Macula S.A, Buenos Aires · Hospital General de Agudos Dr. J. M. Ramos Mejia, Ciudad Autonoma Buenos Aires · Hospital Universitario Austral, Pilar · DIM Clínica Privada, Ramos Mejía · Hospital El Cruce, San Juan Bautista
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Glenny Corp - Centro Medico Saavedra, Buenos Aires · Centro de Investigaciones Metabólicas (CINME), Buenos Aires · IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires · CIPREC, Buenos Aires · Buenos Aires Macula S.A, Buenos Aires · Hospital General de Agudos Dr. J. M. Ramos Mejia, Ciudad Autonoma Buenos Aires · Hospital Universitario Austral, Pilar · DIM Clínica Privada, Ramos Mejía · Hospital El Cruce, San Juan Bautista
Registry updated 2026-10-28
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Buenos Aires · CABA · Capital Federal · Córdoba · Pilar
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Buenos Aires · CABA · Capital Federal · Córdoba · Pilar
Registry updated 2026-10-23
NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Trial Treatment · Phase 3 · Akero Therapeutics, Inc
Buenos Aires · Ciudad Autónoma de Buenos Aires · La Plata · Ramos Mejía · Rosario
Registry updated 2026-10-13
NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Italiano de Buenos Aires, ABB · Cicemo Srl, Buenos Aires · Centro de Investigaciones Metabólicas (CINME), Buenos Aires · Mautalen Salud e Investigación, Buenos Aires · Centro Médico Viamonte, Buenos Aires · Glenny Corp. S.A., Buenos Aires · Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada, Buenos Aires · DOM Centro de Reumatología, Buenos Aires · CIPREC, Buenos Aires · Fundacion Respirar, Buenos Aires · Instituto de Investigaciones Clínicas Córdoba, Córdoba · Centro de Investigaciones Clínicas Baigorria, Granadero Baigorria · Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata · DIM Clínica Privada, Ramos Mejía · INECO Neurociencias Oroño, Rosario · Instituto de Investigaciones Clinicas Rosario, Rosario · Centro de Diagnóstico y Rehabilitación (CEDIR), Santa Fe
Registry updated 2026-10-08
NCT06757348
Fatty Liver and Pancreatic Steatosis
Research · Maria Marta Piskorz
Hospital de Clinicas Jose de San Martin, Ciudad Autonoma de Buenos Aires
Registry updated 2025-08-06

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error